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Objective: Repair approaches for the non-vascular meniscus are rarely developed. Recent strategies use
scaffold-based techniques and inducing factors. The aim of the study was the investigation of cell
recruitment and re-differentiation inducing factors for a scaffold-based meniscus repair approach.
Method: 3D cultivation of in vitro expanded human meniscus-derived cells was performed in high-
density cultures supplemented with 25% hyaluronic acid (HA), 10% human serum (HS) or 10 ng/ml
transforming growth factor (TGF-ß3) compared to untreated controls. The in vitro cell recruitment po-
tential of different HS concentrations was tested by chemotaxis assay. Analysis of chondrocytic markers
(type I, II, IX collagen and proteoglycans) was performed on protein and gene expression level.
Results: Cells were attracted by 1e20% HS. 3D cultures supplemented with 10% HS and 25% HA showed
meniscus-like gene expression proﬁles at day 7 with signiﬁcantly increased cartilage oligomeric matrix
protein (COMP) and aggrecan expression levels in the HS group and a slightly increased proﬁle in the HA
group compared to control. The TGF-ß3 group showed an additional induction of gene expression levels
for type II and type IX collagen. Histological ﬁndings conﬁrmed these results by proteoglycan and type I
collagen staining in all groups and type II collagen staining only in the TGF-ß3 group.
Conclusion: This study demonstrates that human meniscus cells are attracted by HS and allow for
meniscal matrix formation in 3D culture in the presence of HA and HS, whereas TGF-ß3 additive does not
initiate meniscal tissue. Regarding non-vascular meniscus repair, results of this study encourage scaffold-
based repair approaches.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
The meniscus plays a critical role in load transmission, shock
absorption, knee joint stability and congruity1,2. Meniscus injuries
are among the most frequent injuries in orthopedic practice.
Traumatic or degenerative injuries of the non-vascular inner part of
the meniscus fail to heal and often lead to its partial or complete
resection. Disruption of the ﬁbrous meniscus architecture impairs
load transmission and initiates erosion of the adjacent articular: C. Kaps, TransTissue Tech-
Berlin, Germany. Tel: 49-30-
sue.com (U. Freymann),
ulrike.goldmann@charite.de
Sittinger), christian.kaps@
s Research Society International. Pcartilage surface. Consequently, it can lead to the development of
osteoarthritis at 5e10 years post-injury3e5.
Meniscus function is reﬂected by its morphology showing
distinct tissue regions and cell phenotypes6 and ﬁbrocartilage tis-
sue. Therein, type I collagen (90%) provides tensile force resistance
and aggrecan promotes viscoelastic properties, compressive stiff-
ness and tissue hydration3,5.
The application of regenerative strategies to restore meniscus
function and avert the onset of osteoarthritis are a unique oppor-
tunity. Thereby the combination of scaffolds with the potency of
cells to restore functional tissue offers new treatment strategies for
the replacement of non self healing meniscus zones by scaffold-
based approaches7. Currently, two cell-free approaches, based on
animal type I collagen (CMI)8e11 and polyurethane (ACTIFIT) are
under clinical evaluation12,13. Synthetic polymers seem to be
beneﬁcial because of the controllability of porosity, degradation
rate, 3D-structure and mechanical properties. In preclinical studies,ublished by Elsevier Ltd. All rights reserved.
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adjacent articular cartilage compared tomeniscectomy but without
clinical prove in the majority of cases14e16. Based on the long-term
clinical experience with resorbable polyglycolic acid (PGA) or
polylactic-co-glycolic acid (PLGA) scaffolds in the ﬁeld of cell-
based17 and cell-free cartilage repair18e20, ﬁrst in vitro studies for
scaffold-based meniscus repair were recently performed21.
Clinical use of a meniscus implant involves optimal scaffold se-
lection, cell integration and cell stimulation to synthesize and
enhance meniscal extracellular matrix22. For a scaffold-based
approach, selection of an optimal cell source and the inﬂuence of
cell growth and differentiation inducing factors have to be evaluated.
With respect to cells, autologous human meniscus-derived cells,
isolated from surgical debris of patients undergoing partial menis-
cectomy, seem to be a potential cell source, since these cells have the
appropriate phenotype and show a limited immune response4,5.
Concerning growth factors, transforming growth factor (TGF-ß)
was shown to be an effective additive to stimulate proteoglycan
production in meniscus cell cultures23e25 and has been described as
an initial factor for a chondrogenic differentiation of stem cells or
de-differentiated cells in pellet cultures26. In terms of meniscus
repair, it remains unclear if TGF-ß can lead to the desired ﬁbro-
cartilage tissue morphology by type I collagen stimulation without
hyaline-like type II collagen induction. Therefore, other factors be
more important to stimulate the formation of functionally type I
collagen. The application of hyaluronan was shown to have a posi-
tive effect on meniscus healing and could inhibit articular cartilage
degeneration in the rabbit model in the short-time follow-up27e30.
In vitro studies demonstrated, that hyaluronan can promote the
proliferation of meniscus cells without altering of cell morphology
or glycosaminoglycan (GAG) synthesis2. Other studies showed a
chondrogenic differentiation of joint-associated mesenchymal stem
cells by hyaluronan in micro-mass cell cultures31.
Besides cell differentiation, bioactive factors may help to attract
cells from the adjacent tissue to migrate into the defect area and to
initiate extracellular matrix production. In recent studies, human
serum (HS)32 and synovial ﬂuid33 have been shown to recruit hu-
man mesenchymal cells in vitro. This effect is suggested to be
transferable on human meniscus-derived cells.
However, the supplementation of a biomaterial with bioactive
factors and seeding of cells might be advantageous for scaffold-
based meniscus repair. Recently, we have shown that biodegrad-
able PGA scaffolds, afﬁliating good biomechanical properties and an
optimal porosity, facilitate cell ingrowth, proliferation and re-
differentiation of human meniscus-derived cells into meniscus-
like repair tissue21.
This study focuses on the evaluation of bioactive factors for cell
recruitment and re-differentiation regarding its combined use with
bioresorbable PGA-scaffolds in potential cell-based and/or cell-free
meniscus repair approaches. Herein, the in vitromigration potential
of humanmeniscus-derived cells is analyzed under the inﬂuence of
HS. Furthermore, this study evaluates the meniscal differentiation
potential of these cells in TGF-b3-, HS- or hyaluronic acid (HA)-
supplemented 3D micro-mass cultures.
Material and methods
Isolation and monolayer cell culture of human meniscus-derived
cells
Lateral menisci of ﬁve human adult donors (three male, two
female; age 29e72 years, mean age 58.2 years) were obtained from
the Department of Pathology, Charité e University Hospital Berlin
at on average 3 days post-mortem by resection of whole or inner
parts of the lateral meniscus from the right or left donor knee. Forthis study, only meniscus donor tissue with macroscopically no
signs of degeneration or traumatic changes was included. Human
meniscus-derived cells were harvested by enzymatic digestion and
cultured as previously described21. The study was approved by the
ethical review board of the Charité e University Hospital Berlin.
Cell migration assay with HS
Migratory activity of human meniscus cells was analyzed in a
8 mm-pore polycarbonate membrane assay (96 well ChemoTx,
Neuro Probe, USA) according to the manufacturer’s recommenda-
tions. HS was used in concentrations from 0.1% to 100% and pre-
pared by dilution in Dulbecco's Modiﬁed Eagle’s medium (DME
(low glucose)-medium) containing 100 U/ml penicillin and 100mg/
ml streptomycin to a ﬁnal concentration of 0.1, 0.5, 1, 5, 10, 20,
50 and 100% HS. Negative controls contained no HS (0% HS).
Migratory activity of cells from three individual donors (two male,
one female; age 53e72) was analyzed in passage 3. For each tested
serum concentration, 3 104 cells per well were used in triplicates.
After 20 h at 37 C, cells that attached under the polycarbonate
membrane were ﬁxed with acetone/methanol 1:1 (v:v) for 3 min
and counterstained with Hemacolor Rapid Stain (Merck, Germany).
Cells that migrated through the ﬁlter pores were analyzed micro-
scopically. For standardization of the assay, photographs repre-
senting the left, the middle and the right area of the well were
taken. The cells in these representative visual ﬁelds (representing
1.83 mm2 of the total migration area) were counted and the
number of migrated cells was extrapolated to the total migration
area (25 mm2). For presentation of results, the mean number of
migrated cells per HS concentration is presented for the cell
preparation of each individual donor (three donors in total) and
error bars represent 95% conﬁdence interval (CI) (lower/upper
limit). Results were also expressed using the migration index (MI),
calculated as the number of migrated cells/well divided by the
mean number of migrated cells of the negative control (0% HS).
Cell differentiation studies
Re-differentiation capacity of human meniscus-derived cells
(passage 3, n ¼ 5 individual cell preparations) to form meniscus-
like tissue was tested in high-density micro-mass cultures
(250,000 cells/pellet) as previously described34, by adding 10 ng/ml
TGF-ß3 (R&D Systems, USA), 25% hyaluronan (Ostenil, TRB
Chemedica AG, Germany), 10% HS (German Red Cross, Germany) or
insulin-transferrin-sodium selenite and linoleic acid (ITSþ 1, Sigma
Aldrich, Germany) as serum-free negative controls in 63 pellets
each to the standard DME culture medium. In total we examined
1,260 cell pellets for all four groups and for all cell preparations of
ﬁve individual donors. The medium was changed every 2e3 days
and cultures were maintained for up to 28 days.
Gene expression analysis
Cell differentiation potential under the inﬂuence of TGF-b3, HS,
hyaluronan or under serum-free conditions was examined by gene
expression analysis of chondrocytic marker genes like type I
collagen, type II and type IX collagen, aggrecan and cartilage oligo-
meric matrix protein (COMP) at day 0, 7 and 14 (n ¼ 5 individual cell
preparations each), 20 cell pellets per time point and group. Total
RNA was isolated and 590 ng were transcribed into single strand
cDNA using the iScript Kit (BIO-RAD, Germany) according to the
manufacturer’s recommendations. Real-time reverse transcription
polymerase chain reaction (RT-PCR) was performed using the
“SYBR Green PCR Core Kit” (Applied Biosystems, USA) in a real-time
PCR cycler (iCycler, BIO-RAD, Germany). The relative expression of
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nase (GAPDH) was used to normalize the cDNA samples. The gene
expression of deﬁned marker genes (Table I) were analyzed in
triplicates (n ¼ 3). The fold change was calculated according to the
ddCT-method35 in comparison to the serum-free insulin-trans-
ferrin-selenium (ITS)-control at the respective day of cultivation
and to the start of the experiment (d0), indicating expanded
monolayer cells in passage 3 when ﬁrstly re-arranged in 3D high-
density pellet cultures without factor supplementation
(Supplemental Fig. 1 and Supplemental Table I). The mean fold
change of cell preparations from ﬁve individual donors is presented
for each group and error bars represent the lower and upper limit of
the 95% CI.
Histological and immune-histochemical staining
To perform histological evaluation, three pellet samples were
taken for each group at day 28 of cultivation. High-density micro-
mass cultures were histologically analyzed for the presence of pro-
teoglycans by alcian blue eight GS staining (Roth, Germany) and for
type I and type II collagen by immune-histochemical anti-type I/II
collagen staining. Samples (n ¼ 5 individual cell preparations) were
embedded in optimum cutting temperature (OCT) compound at
each time point. Cryosections (6 mm) were used for histological and
immune-histochemical stainings. Sections were incubated for
30 minwith primary rabbit anti-human type I/II collagen antibodies
(both Acris, Germany), colorimetrically detected by 3-amino-9-
ethylcarbazole (AEC) (EnVisionTM þ horseradish peroxidase (HRP)-
System, Dako, Germany) and counterstained with hematoxylin
(Merck, Germany). IgG-isotype control was used to exclude unspe-
ciﬁc antibody bindings. For presentation of alcian blue, type I and
type II collagen staining intensities at day 28, three cell pellet sec-
tions of ﬁve individual cell preparations per group (n ¼ 4: negative
control, HA, HS and TGF-ß3 group) were stained andmicroscopically
evaluated by a subjective scoring system. Thereinminus and plus are
correlated to the staining intensity of the respective staining,
deﬁning “e” for no staining, “þ” for a light staining, “þþ” for a
moderate staining and “þþþ” for an intensive staining.
Statistical analysis
For analysis of chemotactic activity of HS, the cell migration
indices per concentration and donor of three individual cell prep-
arations were analyzed by KruskaleWallis One Way Analysis of
Variance on Ranks. Signiﬁcant differences were considered at
P < 0.05 by multiple comparisons vs the negative control group
(Dunn’s Method). For analysis of the gene expression proﬁle, fold
changes of ﬁve individual cell preparations of each group (HA, HS
and TGF-ß3 group, two time points each: day 7/14) were analyzedTable I
Oligonucleotides of examined genes
Gene Accession no. Oligon
Aggrecan NM_001135 Forwa
Rever
COMP NM_000095 Forwa
Rever
Type I alpha1 collagen NM_000088 Forwa
Rever
Type II alpha1 collagen NM_001844 Forwa
Rever
Type IX alpha 3 collagen NM_000493 Forwa
Rever
GAPDH NM_002046 Forwa
Reverby ManneWhitney Rank Sum Test compared to the serum-free
untreated negative control at the respective culture day and to d0
(Supplemental Fig. 1 and Supplemental Table I). Differences were
considered signiﬁcant at P < 0.05 and a fold change of <2 or >2.
Results
Chemotactic activity of HS on human meniscus-derived cells
Human meniscus-derived cells adhered to the membrane
within 20 h, cells migrated through the pores and ﬁrmly attached to
the lower surface of themembrane. Each of the three individual cell
preparations showed a donor-dependent increasing migratory ac-
tivity with increasing HS concentration of up to 20% [Fig. 1(A)]. HS
concentrations higher than 20% led to a decrease in migration ac-
tivity, showing a minimum at 100% HS. Individual results for cell
preparations showed highest MI of 4.3 at 10% HS for donor 1,
highest MI of 3.1 at 20% HS for donor 2 and highest MI of 3.2 at 20%
HS for donor 3. HS concentrations of 50% and 100% were shown to
attract fewest cells in cell preparation 2 and 3. Statistical analysis of
MI over all cell preparations in comparison to the mean of the
negative control [Fig. 1(B)] showed signiﬁcant differences
(P ¼ <0.001) at HS concentrations of 1%, 5%, 10% and 20%.
Gene expression analysis
Re-differentiation potential of human meniscus-derived cells,
cultured in 3D high-density micro-mass cultures in the presence of
TGF-ß3, HS or hyaluronan, was examined by gene expression
analysis at day 7 and 14. Statistical analysis of fold change data of
chondrocytic marker genes like type I collagen, type II and IX
collagen, aggrecan and COMP compared to serum-free untreated
controls are shown in Fig. 2 and in Table II. Statistical analysis of fold
change data compared to the start of the experiment (d0) are
additionally shown under supplementary data (Supplemental Fig.1
and Supplemental Table I).
In the TGF-b3 group, expression levels of chondrocytic markers
like type II collagen and type IX collagen, predominantly present in
hyaline-like cartilage tissue, and chondrocytic marker genes like
type I collagen, COMP and aggrecan, coding also for meniscal
extracellular matrix components, were signiﬁcantly increased at
day 7 and for COMP also at day 14 when compared to untreated
controls. When compared to d0, a signiﬁcant induction was eval-
uated for type I, II and IX collagen and COMP at day 7 and 14 and for
aggrecan at day 7.
The HS group showed signiﬁcantly increased expression levels
for aggrecan and COMP at day 7 and a signiﬁcant reduction for type
II collagen at day 7 compared to untreated controls. When
compared to d0, a signiﬁcant induction was evaluated for aggrecanucleotide (50e30) Amplicon (base pairs)
rd: GGCTGCTGTCCCCGTAGAAGA 163
se: GGGAGGCCAAGTAGGAAGGAT
rd: CCGGAGGGTGACGCGCAGATTGA 116
se: TGCCCTCGAAGTCCACGCCATTGAA
rd: CGATGGCTGCACGAGTCACAC 180
se: CAGGTTGGGATGGAGGGAGTTTAC
rd: CCGGGCAGAGGGCAATAGCAGGTT 128
se: CAATGATGGGGAGGCGTGAG
rd: AATCAGGCTCTCGAAGCTCATAAAA 149
se: CCTGCCACACCCCCGCTCCTTCAT
rd: GGCGATGCTGGCGCTGAGTAC 100
se: TGGTCCACACCCATGACGA
Fig. 1. A and B: Migration of human meniscus-derived cells subjected to different HS concentrations. The mean number of migrated cells per HS concentration is presented for
the cell preparation of each individual donor (three donors in total) and error bars represent 95% CI (lower/upper limit) (A). The MI is given as the median with the ends of the
boxes deﬁning the 25th and 75th percentiles and error bars deﬁning the 10th and 90th percentiles. Asterisks represent signiﬁcant differences compared to the control group
(*P  0.001) (B).
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signiﬁcantly reduced at day 7.
Upon stimulation with HA, the expression proﬁle of type I
collagen remained mainly stable and showed slightly increased
expression levels for aggrecan and COMP at day 7 and 14 compared
to untreated controls. In comparison to d0, a signiﬁcant induction
was evaluated for COMP at day 14.
Histological and immune-histochemical staining
Meniscus-like matrix formation in 3D pellets at day 28 is pre-
sented in Fig. 3. Cells of all four individual groups were distributed
homogenously within the 3D cell culture. Serum-free untreated
controls revealed very low proteoglycan content after 4 weeks of
cultivation (A), whereas cell pellets treated with TGF-ß3 (D)
showed high content and pellets treated with hyaluronan (G) and
HS (H) showed moderate proteoglycan content.
Untreated controls (B) showed no type I collagen formation
within the 3D culture, whereas type I collagen formation was
shown to be high, when cultures were supplemented with TGF-ß3
(E). Formation of type I collagen was moderate after HA (H) and HS
(K) supplementation.
Serum-free untreated controls (C) and cell pellets treated with
hyaluronan (I) and HS (L) showed no type II collagen formation
within the synthesized extracellular matrix. In contrast to that, type
II collagen formation, characteristically for articular chondrocytic
differentiation and hyaline-like cartilage tissue, was induced when
3D cultures were cultivated in the presence of TGF-ß3 (F).
Subjective scoring of the staining intensities is shown in Table III
for ﬁve individual cell preparations per each group (n ¼ 4) at day28. Therein 3D cultures supplemented with TGF-ß3 showed the
most intensive staining for proteoglycans, type I collagen and type
II collagen. Cultivation with HS led to a moderate proteoglycan and
type I collagen staining and HA supplementation showed only a
light staining of both meniscus matrix components. In contrast to
the TGF-ß3 group, no type II collagen formation was found after
stimulation with HS or HA.
Discussion
This study investigated the migration potential of in vitro
expanded human meniscus-derived cells under the inﬂuence of HS
and its chondrocytic differentiation potential in 3D high-density
micro-mass cultures after stimulation with TGF-ß3, HS or HA. Cell
recruitment and subsequent cell differentiation studies were per-
formed for the evaluation of these supplements for potential
meniscus repair approaches.
Results demonstrated that in vitro expanded human meniscus-
derived cells are able to migrate under the inﬂuence of HS in
concentrations ranging from 1% to 20% HS. Therein, 20 % HS con-
centration showed the highest chemotactic effect on two out of
three individual cell preparations. Higher concentrations of serum
(50% or 100%) did not stimulate the cell migration activity of human
meniscus-derived cells. These results may indicate, that HS or
particular components of the serum like growth factors or che-
mokines dose-dependently recruit human meniscus-derived cells
and that cells show a reduced migratory activity when high-
concentrated application rates are used. This is in concordance
with other studies, showing the recruitment of other human
mesenchymal cells like bone marrow-derived mesenchymal stem
Fig. 2. Real-time gene expression analysis of selected genes. Fold change analysis of chondrocytic marker genes like type I collagen, type II and type IX collagen, aggrecan and COMP is
shown in meniscus-derived high-density micro-mass cultures compared to untreated controls. The mean of ﬁve individual cell preparations is plotted and error bars represent 95%
CI (lower/upper limit). Asterisks represent signiﬁcant differences compared to the control group.
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and mesenchymal progenitor cells32 by serum. In one of these
studies, fetal bovine serum (FBS) dose- and time-dependently
recruited articular chondrocytes among a series of tested growth
factors and cytokines36. Therein also human bone marrow
mesenchymal cells showed signiﬁcant chemotactic activity for 5%
FBS and several growth factors and cytokines36. In the others
studies, HS signiﬁcantly recruited intervertebral disc-derived cells
in concentrations of 0.1e10% in vitro37. This effect might be caused
by the presence of high levels of growth factors and chemokines
found in serum. In particular, chemokines of the synovial ﬂuid33,38
and of the HS were shown to highly stimulate the migration of
mesenchymal cells in several studies as shown for CCL25, CXCL10
and XCL138 and for CXCL-10 and CXCL-1139 and CXCL840. The
concept of the in vivo use of HS for cell recruitment and/or differ-
entiation in soft tissue repair has been shown in recent studies19,32.
In a sheepmodel32 and in ﬁrst clinical applications19, the formation
of hyaline-like repair tissue has been shown in a cell-free scaffold-
based approach for cartilage repair, assuming the cell recruitment
and ingrowth of mesenchymal progenitor cells. Thereby a scaffold
guided tissue repair has been shown after the implantation of a
cell-free scaffold soaked with HS before use. The prospective
intention of our study is to adapt this concept for in vivo meniscusrepair by implanting a cell-free HS soaked scaffold. In a potential
cell-free meniscus repair approach, the examined chemotactic
properties of HS might be used to attract cells from the adjacent
tissue and/or the residual meniscus tissue into the cell-free scaffold
and to induce a scaffold guided tissue repair by the formation of
meniscus-like repair tissue in the defective area. Furthermore, the
inﬂuence of growth or differentiation factors like HS, HA or TGF-ß3,
was evaluated in 3D culture for the induction of chondrocytic genes
and the formation of meniscus-like matrix regarding its potential
use in a meniscus repair approach. In the HS group, a signiﬁcant
induction of COMP and aggrecan, commonly markers of ﬁbro-
cartilage meniscus tissue, and a signiﬁcant reduction of type II
collagen, a prior marker of hyaline cartilage, was shown at day 7 on
gene expression level, when compared to untreated control (ITS-
group). When compared to d0 (start of the experiment), a signiﬁ-
cant induction was also evaluated for aggrecan at day 7 and for
COMP at day 7 and 14, whereas type II collagen remained signiﬁ-
cantly reduced at day 7. Gene expression results of our study are
comparable with previous studies41, showing an increased
expression of aggrecan and COMP at day 7 in bovine meniscus
pellets, when cultured in media with 10 % FBS and compared to
control (ITS-group). Thus, HS seems to support an induction of
chondrocytic meniscus-related marker genes. On protein level, the
Table II
Gene expression analysis (fold change) of 3D meniscus pellet cultures supplemented with HA, HS or TGF-ß3 compared to untreated control (ITS-group)
Group n Fold change Signiﬁcance P-valuea vs ITS-group
Mean CI (95%) lower limit CI (95%) upper limit
Type I collagen
ITS d7 5 1.01 0.93 1.09 e e
ITS d14 5 1.01 0.95 1.07 e e
HA d7 5 1.34 0.62 2.07 No 0.690
HA d14 5 1.16 0.76 1.56 No 0.690
HS d7 5 0.60 0.32 0.88 No 0.151
HS d14 5 0.72 0.32 1.12 No 0.151
TGF-ß3 d7 5 3.93 2.25 5.60 Yes 0.008
TGF-ß3 d14 5 5.56 2.85 8.26 No 0.151
Aggrecan
ITS d7 5 1.01 0.94 1.08 e e
ITS d14 5 1.01 0.93 1.10 e e
HA d7 5 1.30 0.85 1.75 No 0.690
HA d14 5 2.83 1.04 4.62 No 0.690
HS d7 5 4.92 2.76 7.09 Yes 0.008
HS d14 5 10.30 4.07 16.52 No 0.151
TGF-ß3 d7 5 25.45 16.21 34.68 Yes 0.008
TGF-ß3 d14 5 69.62 41.52 97.72 No 0.151
COMP
ITS d7 5 1.02 0.91 1.13 e e
ITS d14 5 1.01 0.92 1.10 e e
HA d7 5 2.25 1.65 2.85 No 0.151
HA d14 5 2.04 1.51 2.58 No 0.151
HS d7 5 5.41 3.51 7.32 Yes 0.008
HS d14 5 3.51 2.28 4.73 No 0.151
TGF-ß3 d7 5 30.96 17.97 43.96 Yes 0.008
TGF-b3 d14 5 6.45 4.36 8.54 Yes 0.008
Type II collagen
ITS d7 5 1.03 0.90 1.16 e e
ITS d14 5 1.01 0.93 1.10 e e
HA d7 5 0.40 0.15 0.65 No 0.151
HA d14 5 9.04 0.59 18.67 No 0.151
HS d7 5 0.41 0.18 0.65 Yes 0.008
HS d14 5 3.45 0.84 7.74 No 0.151
TGF-ß3 d7 5 798.42 38.19 1,558.65 Yes 0.008
TGF-ß3 d14 5 1082,441.53 57,765.20 2222,648.27 No 0.690
Type IX collagen
ITS d7 5 1.16 0.84 1.49 e e
ITS d14 5 1.02 0.91 1.14 e e
HA d7 5 0.57 0.38 0.75 No 0.008
HA d14 5 0.53 0.27 0.78 No 0.151
HS d7 5 1.47 0.73 2.22 No 0.690
HS d14 5 0.53 0.20 0.86 No 0.151
TGF-ß3 d7 5 113.55 11.82 215.28 Yes 0.008
TGF-ß3 d14 5 864.77 255.74 1,473.79 No 0.151
a ManneWhitney rank sum test.
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collagen in contrast to untreated controls and, in contrast to the
TGF-ß3 group, no type II collagen formation as characteristical for
hyaline-like tissue. Therefore we conclude, that HS can lead to an
appropriate meniscus-like tissue formation by potentially
improving the matrix architecture due to protein assembly and
homogenous protein arrangement and by enriching and/or accu-
mulating of meniscal extracellular matrix components. Results of
HS for 3D cultivation of meniscus cells indicate, that HS seems to be
a potential additive for meniscus repair approaches.
In the HA group, the expression proﬁle of type I collagen
remained mainly stable and showed slightly increased expression
levels for aggrecan and COMP and at day 7 and 14 compared to
untreated controls. In comparison to d0, a signiﬁcant inductionwas
evaluated for COMP at day 14, which was described as a commonly
marker of native meniscus tissue in previous studies42,43. In
contrast to the TGF-ß3 group and to another study31, showing a
hyaline-like cartilage tissue formation with type II collagen syn-
thesis induced by HA in 3D pellets of mesenchymal progenitor cells,
no synthesis of type II collagen was evaluated on protein or genelevel in our study. Histological results of our study conﬁrmed the
positive effect of HA on ﬁbrocartilaginous meniscus tissue forma-
tion by the accumulation of proteoglycans and type I collagen in
contrast to a lack thereof in the untreated control (ITS-group).
Therefore and since the positive effect of HA in combination with
HS was shown to support a chondrogenic re-differentiation of
meniscus cells and a meniscus-like tissue formation in 3D scaffold
cultures24 and was reported to be beneﬁcial on meniscus healing
and inhibition of articular cartilage degeneration in a rabbit
model27,29,30, we believe that HA may be a useful factor in a
scaffold-based approach.
In the TGF-b3 group, signiﬁcant induced expressions of type I
collagen, COMP and aggrecan, coding for meniscal extracellular
matrix components, and for type II and type IX collagen, found in
high ratios in hyaline-like cartilage like, was signiﬁcantly increased
were evaluated at day 7. Thus, the stimulation with TGF-ß3 seems
to result in an additional induction of chondrocytic markers, which
are more associated with hyaline-like cartilage tissue. Histological
results conﬁrm these ﬁndings on protein level by an intensive type
II collagen staining at day 28. As previously described by other
Fig. 3. AeL: Histological and immune-histochemical staining of untreated and stimulated meniscus-derived cell pellet sections at day 28. The untreated controls revealed no
proteoglycans (A), whereas cell pellets treated with TGF-ß3 (D), hyaluronan (G) and HS (H) showed a proteoglycan-rich matrix stained by alcian blue. Serum-free controls (B)
showed no type I collagen formation within the cell pellet, whereas type I collagen is present when pellets were cultured in the presence of HA (H), TGF-ß3 (E) and HS (K). Serum-
free controls (C) and cell pellets treated with hyaluronan (I) and HS (L) showed no type II collagen formation within the cell pellet, whereas type II collagen is present when pellets
are cultured in the presence of TGF-ß3 (F).
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teoglycans and type II collagen in meniscus 3D micro-mass and
scaffold cultures, but did not abundantly increase the formation of
type I collagen over time. Type I collagen plays an important role for
native meniscus function and tensile strength of the meniscus tis-
sue. Regarding a factor-induced meniscus repair approach, the
application of TGF-ß3 did not markedly initiate an aspired ﬁbro-
cartilage tissue formation and may elicit some negative effects on
meniscus tissue formation. Therefore, it is suggested to be an un-
suitable factor in a potential meniscus repair approach.
The outcome of this study suggests, that resident human
autologous meniscus cells may have the capability to migrate to
the defect site, can differentiate into a meniscal phenotype and
are able to synthesize meniscus-like repair tissue. In a recent
study, the application of biomaterials like PGA in combination
with HS, hyaluronan and autologous meniscus cells was already
shown to be effective for the cultivation of cell-based meniscusconstructs21. Therein, meniscus-derived cells were shown to
proliferate, to maintain their cell vitality and to re-differentiate
into meniscus-like repair tissue in 3D scaffold-based cultures21.
The treatment of lesions with a cell-based or even cell-free
approach based on PGA or PLGA scaffolds, shown to be efﬁcient
for clinical articular cartilage regeneration17e20, may be also
beneﬁcial for meniscus non-vascular lesions repair. Cell-free
scaffolds with these capabilities can reduce donor-side
morbidity, are ready to use, available off the shelf and can be
implanted in a one-step procedure using minimally invasive
surgery for meniscal repair.
However, this study has some limitations. Characterization of
meniscus 3D cultures is limited to histological and gene expression
proﬁle evaluation and lacks of quantitative protein assessments.
Also all examinations were performed on a pool of cells derived
from whole meniscus tissue, without discrimination between
distinct meniscus regions or cell phenotypes and by using older
Table III
Intensity of alcian blue and type I/II collagen stainings at day 28
Staining Group Staining intensity at day 28 (subjective scoring)
Donor 1 Donor 2 Donor 3 Donor 4 Donor 5
Alcian blue staining NC e þ e e e
TGF-ß3 þþþ þþþ þþþ þþþ þþþ
HA þ þþ þ þþ þþ
HS þþ þ þþ þþ þþ
Anti type I collagen
staining
NC e e e e þ
TGF-ß3 þþþ þþþ þþþ þþþ þþþ
HA þ þ þ þþ þþ
HS þþ þþ þþ þ þþ
Anti type II collagen
staining
NC e e e e e
TGF-ß3 þþþ þþþ þþþ þþ þþþ
HA e e e e e
HS e e þ e e
e, no staining; þ, light staining; þþ, moderate staining; þþþ, intensive staining.
NC, serum-free.
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assisted meniscus repair approach. In further studies, cell re-
differentiation into meniscus-like tissue has to be evaluated in
clinical applicable and factor-supplemented biomaterials to esti-
mate its potency for non-vascular meniscus repair. Furthermore,
preclinical animal studies for the proof of meniscus repair have to
follow.
In summary, human autologous meniscus cells obviously have
the potential to migrate under the inﬂuence of HS in a
concentration-dependent manner. Furthermore, these cells
showed an induction of chondrocytic marker genes and the for-
mation of meniscus-like extracellular matrix in the presence of HS
and, to a lesser extent, hyaluronan when cultivated in 3D pellet
cultures. Regarding a potential biological repair of traumatic and/or
degenerative meniscus non-vascular lesions and the long-term
prevention of knee osteoarthritis, results of our study may indi-
cate, that these supplements and cells might be beneﬁcial for a
scaffold-based meniscus repair.Author contribution
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